Senti Biosciences, Inc. operates as a gene circuit company. The company develops cell and gene therapies engineered with gene circuits that are designed to reprogram cells with biological logic to sense inputs, compute decisions, and respon...
Q1 2026
May 5, 2026
FY 2025
Mar 27, 2026
Q4 2025
Q3 2025
Nov 13, 2025
Q2 2025
Aug 7, 2025